open access

Vol 76, No 7 (2018)
Editorials
Published online: 2018-07-06
Submitted: 2018-05-08
Accepted: 2018-05-08
Get Citation

Concomitance of cardiovascular and pulmonary disorders: mutual bystanders or causal interactions?

Peter Alter, Rudolf A. Jörres
DOI: 10.5603/KP.2018.0132
·
Kardiol Pol 2018;76(7):1027-1028.

open access

Vol 76, No 7 (2018)
Editorials
Published online: 2018-07-06
Submitted: 2018-05-08
Accepted: 2018-05-08

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Concomitance of cardiovascular and pulmonary disorders: mutual bystanders or causal interactions?

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 76, No 7 (2018)

Pages

1027-1028

Published online

2018-07-06

DOI

10.5603/KP.2018.0132

Bibliographic record

Kardiol Pol 2018;76(7):1027-1028.

Authors

Peter Alter
Rudolf A. Jörres

References (15)
  1. Polak M, Doryńska A, Szafraniec K, et al. Cardiovascular risk assessment, cardiovascular disease risk factors, and lung function parameters. Kardiol Pol. 2018 [Epub ahead of print].
  2. Peasey A, Bobak M, Kubinova R, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health. 2006; 6: 255.
  3. Conroy RM, Pyörälä K, Fitzgerald AP, et al. SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11): 987–1003.
  4. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186(2): 155–161.
  5. Kahnert K, Alter P, Young D, et al. The revised GOLD 2017 COPD categorization in relation to comorbidities. Respir Med. 2018; 134: 79–85.
  6. Fisher KA, Stefan MS, Darling C, et al. Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study. Chest. 2015; 147(3): 637–645.
  7. de Lucas-Ramos P, Izquierdo-Alonso JL, Rodriguez-Gonzalez Moro JM, et al. Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). Int J Chron Obstruct Pulmon Dis. 2012; 7: 679–686.
  8. Miller J, Edwards LD, Agustí A, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013; 107(9): 1376–1384.
  9. Hawkins NM, Huang Z, Pieper KS, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2009; 11(3): 292–298.
  10. Kawut SM, Poor HD, Parikh MA, et al. Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study. J Am Coll Cardiol. 2014; 64(19): 2000–2009.
  11. Watz H, Waschki B, Meyer T, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest. 2010; 138(1): 32–38.
  12. Alter P, Jörres RA, Watz H, et al. Left ventricular volume and wall stress are linked to lung function impairment in COPD. Int J Cardiol. 2018; 261: 172–178.
  13. Alter P, Watz H, Kahnert K, et al. Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling. Respir Med. 2018; 137: 14–22.
  14. Hohlfeld JM, Vogel-Claussen J, Biller H, et al. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. Lancet Respir Med. 2018; 6(5): 368–378.
  15. Alter P, Watz H, Kahnert K, et al. Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD. Am J Respir Critical Care Med. 2018; 197: A4989.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl